GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the full-length human rage extracellular domain (VC1C2 fragment)

Analyse Crystal structure of the full-length human rage extracellular domain (VC1C2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4LP5
Type
protein
Length
513 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Advanced glycosylation end product-specific receptor
UniProt
Q15109
Pockets
4 · best druggability 0.49

Structure

x-ray diffraction · 2 distinct chains · 1% helix, 47% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BAdvanced glycosylation end product-specific receptorprotein2110% helix, 45% strandQ15109
AAdvanced glycosylation end product-specific receptorprotein3022% helix, 48% strandQ15109

Pockets

4 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11240.490.7920empty
2830.390.7718empty
3860.330.7422empty
4640.280.7316empty

Interfaces

1 interface between chains.

  • B–A · 683 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 4LP5 · Crystal structure of the full-length human RAGE extracellular domain (VC1C2 fragment) · the same entry in another collection · chain B against B, TM-score 1.00
  • Q15109 · AlphaFold monomer V2.0 prediction for advanced glycosylation end product-specific… · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.